• Mashup Score: 1

    Cancer immunotherapeutics work by unleashing the power of a patient’s immune system to fight cancer and have emerged as one of the most exciting new approaches to cancer treatment. As of July 31, 2023, at least 23 different cancer immunotherapeutics have been approved by the FDA.

    Tweet Tweets with this article
    • Immunotherapeutics have emerged as one of the most exciting new approaches to cancer treatment. Learn more in a special section on Immunotherapy: Pushing the Frontier of Cancer Medicine in the AACR #CancerProgressReport: https://t.co/NyYxgSoplA #CancerResearchSavesLives https://t.co/Co6n6zdCr5